KTH 4 Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, indicated for the management of musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal disorders. Etoricoxib, a selective COX-2 inhibitor, exerts anti-inflammatory, analgesic, and antipyretic effects by selectively inhibiting cyclooxygenase-2 enzyme, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Thiocolchicoside is a muscle relaxant with anti-inflammatory properties that acts by modulating glycine receptors and inhibiting excitatory neurotransmission, resulting in relief from muscle spasms and stiffness. The combination of these agents provides synergistic benefits by addressing both inflammatory pain and muscle spasm, improving patient mobility and comfort. KTH 4 Tablet is typically prescribed for short-term use under medical supervision, with caution advised in patients with cardiovascular risk factors, gastrointestinal disorders, hepatic or renal impairment. Common adverse effects may include gastrointestinal discomfort, dizziness, and hypersensitivity reactions. It is contraindicated in patients with known hypersensitivity to either component, active peptic ulcer disease, or severe hepatic impairment. Consultation with a healthcare professional is essential before initiating therapy to ensure appropriate use and monitoring.

Dosage & How to Use